Sign In / Register          (0)
Nucleus-based Yeast Two-Hybrid Screening

Nucleus-based Yeast Two-Hybrid Screening

Background

Introduction

Protein interaction analysis remains a cornerstone of functional genomics, with the nucleus-based yeast two-hybrid (Y2H) system standing as a pivotal tool for detecting direct molecular interactions. Originating from the groundbreaking work of Stanley Fields and Ok-Kyu Song in the early 1990s, this method has evolved into a high-throughput screening platform, enabling systematic mapping of interactomes under native nuclear conditions. By coupling bait-prey fusion constructs with selectable reporters, the system efficiently identifies binding partners while minimizing cytoplasmic interference, making it indispensable for unraveling signaling networks and drug target discovery.

Ready to explore protein networks with precision? Partner with Profacgen to leverage our expertise in high-throughput yeast two-hybrid screening and advanced functional genomics.

Unlock Your Project's Potential with Profacgen

Why Choose Nucleus-based Yeast Two-Hybrid Screening?

This method combines cost-effective screening with high sensitivity to detect weak/transient eukaryotic protein interactions in their native nuclear context. Customizable assays (e.g., promoter-reporter systems, PTM-compatible strains) ensure adaptability to diverse targets, while nuclear localization preserves physiologically relevant interactions, including post-translationally modified proteins. Ideal for mapping signaling hubs or drug targets, it bridges biochemical relevance with scalability unmatched by in vitro approaches.

The GAL4 system in yeast two-hybrid assays.Fig1. GAL4 system was used to detect protein interaction in yeast two-hybrid experiment.

Applications Across Industries

Types Description
Biomedical Research
  • Drug Discovery: Accelerate target validation by identifying critical PPIs involved in disease pathways (e.g., oncoprotein networks), enabling rational design of small-molecule inhibitors or biologics.
  • Disease Mechanism Studies: Decipher molecular drivers of disorders like neurodegeneration or autoimmune diseases by mapping aberrant interaction hubs.
  • Therapeutic Target Identification: Prioritize druggable targets by screening for high-affinity interactions between host proteins and pathogen effectors (e.g., viral-host PPIs).
Agricultural Sciences
  • Crop Improvement: Engineer stress-tolerant crops by characterizing plant protein interactions involved in drought, salinity, or pest resistance (e.g., transcription factor complexes).
  • Trait Optimization: Uncover interactions between growth-regulating proteins to develop high-yield varieties with enhanced nutritional profiles.
  • Disease Resistance Breeding: Identify pathogen-responsive PPIs in crops to guide CRISPR-based editing for durable disease resistance.
Industrial Biotechnology
  • Enzyme Engineering: Optimize industrial enzymes (e.g., cellulases, lipases) by screening mutant libraries for improved catalytic efficiency or stability via subunit interaction analysis.
  • Metabolic Pathway Optimization: Rewire microbial metabolic networks by mapping rate-limiting enzyme complexes, enhancing biofuel or bioplastic production.
  • Biosensor Development: Design synthetic PPIs for real-time metabolite detection in bioreactors, enabling precision fermentation control.

Inquiry Now

Service Procedure

Sample Submission Requirements

We're eager to assist you in exploring protein interactions with our Nucleus-based Yeast Two-Hybrid Screening service! To ensure a seamless start to your project, please provide the following information and samples:

Delivery

Service Scope

Bait Vector Construction
We provide complete support for constructing your bait vector, including primer design, gene amplification, and validation of cloning. Our team ensures that your bait vector is fully prepared for the screening process.
Library Screening
Our high-throughput screening process utilizes either standardized cDNA libraries or custom libraries provided by you. This approach helps us efficiently identify potential protein interactions.
Self-Activation Test
We perform self-activation tests on bait vectors to confirm that they do not activate reporter genes independently. This step is essential for ensuring the accuracy and reliability of your screening results.
Positive Clone Identification
We identify positive clones through PCR, sequencing, and BLAST alignment. Detailed information on interaction partners is provided to help you interpret the results.
Back Transformation and Validation
We conduct back-transformation and validation experiments to verify the reliability of identified interactions. This ensures that the detected interactions are genuine and reproducible.
Customized Solutions
We recognize that each research project has unique requirements. Therefore, we offer customized services tailored to your specific needs, including optimization for special protein screening and comprehensive technical support.

Inquiry Now

Why Choose Profacgen?

High-Quality Screening with Low False Positives

Profacgen utilizes advanced yeast strains and multiple reporter genes to minimize false positives, ensuring that the interactions identified are highly reliable and relevant to your research.

Customized Solutions for Your Research Needs

We understand that every project is unique. Profacgen offers fully customized services, from bait vector construction to specialized cDNA library screening, tailored to meet your specific experimental requirements.

Expert Technical Support Throughout Your Project

Our team of experts is dedicated to supporting you from start to finish. We offer consultation on experimental design, troubleshooting, and data interpretation to ensure your project's success.

Wide Range of Ready-to-Use Libraries

We offer a diverse selection of standardized cDNA libraries for various species and tissues. If you have a custom library, we can also work with that, providing flexibility to suit your needs.

Commitment to Research Success

At Profacgen, we are dedicated to helping you achieve your research goals. Our commitment to excellence and customer satisfaction ensures that you receive the highest quality service and support.

Case Study

* NOTE: We prioritize confidentiality in our services to safeguard technology and intellectual property for enhanced future value and protection. The following case study has been shared with the client's consent.

Project 1: Y2H Library Construction

Goal

To construct a yeast two-hybrid (Y2H) library for a specific sample provided by the customer. The library was built using RNA extracted from the provided tissues and transformed into E. coli TOP10 cells.

Results

  • RNA Quality
    The extracted RNA showed good quality with clear 28S and 18S bands and no degradation. The OD260/OD230 ratio was greater than 2, indicating high purity.

RNA Has Good Quality and No Degradation.Fig2. Agarose Gel Electrophoresis and Spectrophotometer Measurement of Total RNA.

  • ds cDNA Synthesis
    The synthesized ds cDNA showed diffuse bands of various sizes on agarose gel electrophoresis, indicating successful synthesis.

Result of ds cDNA Synthesis.Fig3. Agarose Gel Electrophoresis of cDNA.

  • Normalization and Small Fragment Removal
    The normalized ds cDNA showed no obvious bright bands and few fragments below 500 bp, confirming successful normalization and removal of small fragments.

Result of Normalization and Small Fragment Removal.Fig4. Agarose Gel Electrophoresis Detection of Homogenization and Removal of Small Fragments.

  • Clone Counting
    The library capacity was determined to be xxx cfu/mL, with a total clone number of xxx.

Clone Counting.Fig5. E. coli Colony Count.

  • Library Quality Identification
    The average insert size of the library was approximately 1,000 bp, as confirmed by colony PCR and agarose gel electrophoresis.

Library Quality Identification.Fig6. Library quality assessment.

Conclusions and Discussions

The Y2H library was successfully constructed with a total CFU of xxx. The average insert size (AIS) of the library was greater than 1,000 kb. The library is suitable for downstream applications in yeast two-hybrid screening.

Project 2: Protein Interaction Verification by Y2H

Goal

To verify custom protein interactions using the yeast two-hybrid (Y2H) system. Specifically, the target proteins RING-3, SNF, and MAPK were constructed into the bait vector pGBKT7, while the protein W4 was constructed into the prey vector pGADT7. The interactions between these proteins were tested by co-transforming the vectors into the AH109 yeast strain and verifying the interactions using the reporter genes HIS3 and ADE2.

Results

  • Six monoclones of each transformant were randomly selected for PCR detection, and correct monoclones were preserved.
  • The positive control (pGADT7-largeT & pGBKT7-p53) grew on both SD-TL and SD-TLHA plates, while the negative control (pGADT7-largeT & pGBKT7-laminC) failed to grow on the SD-TLHA plate due to its inability to activate the ADE2 and HIS3 reporter genes.
  • The combinations of pGADT7-W4 with pGBKT7-RING-3, pGBKT7-SNF, and pGBKT7-MAPK could grow on both SD-TL and SD-TLHA plates, indicating interactions between W4 and RING-3, SNF, and MAPK, respectively. None of the proteins showed self-activation.

Positive Clone Screening Results.Fig8. Positive Clones Detected with HIS3 and ADE2 Reporter Genes.

Conclusions and Discussions

The project was successfully completed. The interactions between W4 and RING-3, SNF, and MAPK were confirmed through the activation of the HIS3 and ADE2 reporter genes.

Customer Testimonials

FAQs

Q: What is the main advantage of nuclear-based Yeast Two-Hybrid Screening?
A: Nuclear-based Yeast Two-Hybrid Screening specializes in analyzing protein-protein interactions within a eukaryotic nuclear environment, closely mimicking natural cellular conditions. This method offers superior accuracy for studying transcription factors, nuclear signaling pathways, and chromatin-related proteins, making it ideal for detecting weak or transient interactions critical to drug discovery and functional genomics research.
A: Our service includes full bait vector construction using your provided gene sequence, cDNA/gDNA samples, or validated accession numbers. We employ advanced cloning techniques like Gateway® and Gibson Assembly, followed by Sanger sequencing to ensure plasmid accuracy, streamlining your workflow from gene submission to ready-to-use vectors.
A: We ensure reliability through a multi-layered validation system combining dual reporter genes (HIS3/LacZ), autoactivation controls, and interaction specificity tests. Optional orthogonal validation methods like Co-IP or Bimolecular Fluorescence Complementation (BiFC) further confirm interactions, significantly reducing false positives while maintaining high-throughput efficiency.
A: Our bioinformatics team delivers comprehensive analysis, including pathway mapping via STRING database integration, domain interaction modeling, and tissue-specific expression profiling. We prioritize clinically relevant targets using evolutionary conservation data and custom scoring systems, helping you translate raw interaction data into actionable insights.
A: We accept diverse samples tailored to your project phase: synthetic genes for early-stage research, purified protein domains for validation, or tissue lysates for discovery-phase studies. Our experts provide optimization guidelines to ensure sample compatibility, solubility, and epitope accessibility for robust interaction screening.
A: Our pricing is competitive and tailored to your specific needs. We offer both standard and customized packages. Contact us for a detailed quote.

Resources

See the procedure of yeast two hybrid screening service and Our experts will design your yeast two hybrid screening experiment according to your specific requirements and we will provide detail data of the result and procedure. Click here to download the Service Instruction.

See more details on the principle and protocol of yeast two hybrid screening on our website. See more…

Online Inquiry

Fill out this form and one of our experts will respond to you within one business day.